These advancements position microneedle technology as a transformative approach for delivering GLP-1 receptor agonists, offering the potential to improve therapeutic adherence, minimize systemic side effects, and support decentralized care models for diabetes management [43]
Employers are turning to enhanced eligibility criteria, vendor-managed programs, and integration with lifestyle or weight-management initiatives to better control utilization and assess value, according to the surveys
Mild nausea or vomiting (common early on) can cause fluid loss
In the era of GLP-1 drugs, demand for bariatric surgery plunges. STAT
But for people who stick with the recommended dosage and drink plenty of water, the health benefits are real
Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025